Therefore, IRF1, IRF3, IRF5, and IRF9 are all involved in the development of HCC, and further research into the molecular mechanisms involving IRFs in carcinogenesis could facilitate the discovery of new targeted therapies. This evidence concerns the gene IRF3 and hepatocellular carcinoma.